z-logo
Premium
A phase II study of carfilzomib in the treatment of relapsed/refractory mantle cell lymphoma
Author(s) -
Lee Hun J.,
Badillo Maria,
Romaguera Jorge,
Wang Michael
Publication year - 2019
Publication title -
british journal of haematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.907
H-Index - 186
eISSN - 1365-2141
pISSN - 0007-1048
DOI - 10.1111/bjh.15107
Subject(s) - carfilzomib , mantle cell lymphoma , medicine , cyclin d1 , oncology , lenalidomide , proteasome inhibitor , lymphoma , multiple myeloma , cancer research , cancer , cell cycle

This content is not available in your region!

Continue researching here.

Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom